Garden Stage Limited (NASDAQ:GSIW – Get Free Report) fell 5.7% during trading on Friday . The stock traded as low as $15.59 and last traded at $16.19. Approximately 30,309 shares changed hands during trading, an increase of 10% from the average session volume of 27,597 shares. The stock had previously closed at $17.16.
Analysts Set New Price Targets
Separately, Weiss Ratings downgraded shares of Garden Stage from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, August 5th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.
Get Our Latest Stock Analysis on Garden Stage
Garden Stage Stock Performance
Garden Stage (NASDAQ:GSIW – Get Free Report) last released its quarterly earnings results on Friday, July 31st. The company reported ($11.69) EPS for the quarter. The business had revenue of $1.94 million during the quarter.
Hedge Funds Weigh In On Garden Stage
A hedge fund recently raised its stake in Garden Stage stock. XTX Topco Ltd increased its stake in Garden Stage Limited (NASDAQ:GSIW – Free Report) by 244.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 258,052 shares of the company’s stock after purchasing an additional 183,147 shares during the period. XTX Topco Ltd owned 0.72% of Garden Stage worth $33,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 0.47% of the company’s stock.
Garden Stage Company Profile
Garden Stage Limited, through its subsidiaries, provides securities dealing and brokerage, underwriting and placing, and other financial services in Hong Kong. It also offers asset management services comprising discretionary account management and fund management services. The company was incorporated in 2022 and is headquartered in Central, Hong Kong. Garden Stage Limited operates as a subsidiary of Oriental Moon Tree Limited.
Recommended Stories
- Five stocks we like better than Garden Stage
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Garden Stage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Garden Stage and related companies with MarketBeat.com's FREE daily email newsletter.
